SCHEMBL3343786

SCHEMBL3343786

Cc1ccc(-c2ccn(CCO)n2)cc1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
NR5A2 O00482 1/20 0.38
SYK P43405 1/20 0.38
PARP1 P09874 1/20 0.37
PDK2 Q15119 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM1A O60341 1/20 0.35
HDAC1 Q13547 1/20 0.35
AR P10275 1/20 0.35
CLK1 P49759 1/20 0.34
DYRK1A Q13627 1/20 0.34
ITGB1 P05556 2/20 0.34
ITGA4 P13612 2/20 0.34
HSP90AA1 P07900 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346669 0.84 MKNK1 (0.53) MKNK1MKNK2SYKPARP1KMT2A
SCHEMBL3343238 0.82 MEN1 (0.46) KMT2AMEN1SMN1; SMN2PDE4DALDH1A1
SCHEMBL3346285 0.82 HDAC3 (0.38) SYKKMT2AMEN1NPC1HDAC1
SCHEMBL3343791 0.81 SMN1; SMN2 (0.41) NR5A2KMT2AMEN1NPC1SMN1; SMN2
SCHEMBL3342747 0.77 HDAC3 (0.46) PDK2KMT2AMEN1HDAC1ALDH1A1
SCHEMBL3343071 0.77 HDAC3 (0.39) MKNK1MKNK2HDAC1SIRT3TDP1
SCHEMBL3341313 0.75 HRH3 (0.43) SYKKMT2AMEN1PDE4DPDE7A
SCHEMBL20442664 0.74 SMN1; SMN2 (0.42) KMT2AMEN1NPC1SMN1; SMN2KDM1A
SCHEMBL3342117 0.74 PDE4D (0.39) MKNK1MKNK2SYKNPC1SMN1; SMN2
SCHEMBL3343187 0.72 P2RX7 (0.47) MKNK1MKNK2SYKPDK2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 MKNK1 2405/4885MKNK2 2356/4885NR5A2 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.